KEGG analysis also revealed that TMEM170B is involved in the p53 signaling pathway, which indicates that the presence of TMEM170B may inhibit the occurrence of TP53 mutations and then exert a tumor suppressor effect in PAAD. The gene discussed is TP53; the disease is pancreatic adenocarcinoma.